ASML cautions investors regarding Tutanota LLC’s “mini-tender” offer
- None.
- Tutanota 's 'mini-tender' offer to ASML shareholders is below market value, conditioned on share price exceeding offer price, and lacks investor protections.
- Mini-tender offers like Tutanota's aim to acquire less than five percent of a company's shares, avoiding SEC disclosure requirements and providing investor safeguards.
Insights
The mini-tender offer by Tutanota LLC for ASML's shares is a financial maneuver that warrants scrutiny. Investors should note that such offers are often made below current market value, as is the case with Tutanota's bid of $1,075 per share. The conditional nature of the offer, hinging on the share price exceeding the offer price, poses a risk for shareholders who might lock in a sale at a suboptimal price. It's imperative to consider the liquidity position and the potential impact on share price if a significant number of shares are tendered. The fact that Tutanota expects to extend the offer until the share price exceeds the offer price indicates a speculative strategy that may not align with shareholder interests.
Furthermore, the avoidance of SEC disclosure and procedural requirements due to the size of the offer being less than five percent of ASML's shares is a red flag. This lack of transparency can leave shareholders without the full picture, potentially leading to uninformed decision-making. Shareholders should be aware of the implications of tendering their shares under these conditions, including the possibility of losing out on future gains if the share price appreciates post-offer period.
From a legal standpoint, the nature of mini-tender offers like the one presented by Tutanota LLC requires attention to the nuances of securities regulation. Mini-tender offers bypass certain SEC regulations that are designed to protect investors in larger tender offers. This includes detailed disclosure requirements and procedural safeguards. Investors should be cautious and may wish to seek legal counsel before participating in such offers. The recommendation by ASML for shareholders to reject the offer and, if already tendered, to withdraw, is a protective measure that underscores the potential legal complexities and risks involved in mini-tender offers.
The legal framework governing these offers is complex and the SEC's previous cautions about mini-tender offers are a testament to their controversial nature. Shareholders should be fully informed of their rights, including the right to withdraw tendered shares and the potential legal ramifications of participating in an offer that may not afford them the same protections as larger, regulated tender offers.
Analyzing the market implications of Tutanota's mini-tender offer for ASML shares, it's evident that the offer price is a critical factor. The offer being below the current market price suggests that Tutanota is attempting to capitalize on short-term market fluctuations. This could potentially undervalue ASML's shares for participating investors. Market trends indicate that such offers can create a temporary distortion in the stock's trading volume and price. It's essential for investors to assess the offer against current market conditions and future growth prospects of ASML.
Additionally, the strategy to extend the offer until the market price exceeds the offer price could signal an expectation of market volatility or a forecasted increase in ASML's share value. This tactic might pressure shareholders into tendering their shares prematurely. The historical performance and market position of ASML should be carefully weighed against the terms of the offer. Investors would benefit from considering long-term value creation versus the immediate, albeit uncertain, gain proposed by Tutanota.
ASML cautions investors regarding Tutanota LLC’s “mini-tender” offer
VELDHOVEN, the Netherlands, March 28, 2024 – ASML Holding NV (ASML) today announced that it recently became aware of an unsolicited “mini-tender” offer by Tutanota LLC to purchase up to 250,000 (two hundred and fifty thousand) of ASML’s ordinary shares, nominal value
ASML is not associated in any way with Tutanota or its mini-tender offer and recommends that shareholders reject this unsolicited mini-tender offer. Any shareholder considering tendering to the offer should exercise caution, carefully review the Tutanota offer documents, obtain current market quotations for their shares and consult with their broker or financial adviser.
ASML recommends that shareholders do not tender their shares in response to Tutanota’s offer because Tutanota’s offer is conditioned on, among other things, the closing price per share of ASML’s ordinary shares exceeding the offer price on the last trading day before the offer expires and is subject to numerous additional conditions, including Tutanota obtaining financing for the offer. Tutanota also states in its offer documents that it expects to extend the offer for successive periods of up to 180 days until the market price of ASML’s ordinary shares exceeds the offer price. This means that ASML shareholders who tender their shares in the offer would receive a below-market price for their shares if the offer conditions are satisfied and shares are purchased in the offer.
According to Tutanota’s offer documents, shareholders who have already tendered their shares may withdraw them by following the procedures described in the offer documents. ASML recommends shareholders who have already tendered their shares to consider withdrawing their tendered shares.
Tutanota has made similar unsolicited mini-tender offers for stock of other public companies. Mini-tender offers seek to acquire less than five percent of a company’s outstanding shares, thereby avoiding many disclosure and procedural requirements of the SEC that would otherwise apply. As a result, mini-tender offers do not provide investors with the same level of protections as provided by larger tender offers under U.S. securities laws. The U.S. Securities and Exchange Commission (“SEC”) has cautioned investors about these offers, issuing the guidance available at https://www.sec.gov/reportspubs/investor-publications/investorpubsminitend. ASML also strongly encourages brokers, dealers and other market participants to exercise caution and to review the SEC’s letter regarding broker-dealer mini-tender offer dissemination and disclosure at https://www.sec.gov/divisions/marketreg/minitenders/sia072401.htm.
ASML warns investors that the offer does not comply with, and does not offer the protections of, the public offer regulations of the Dutch Financial Markets Supervision Act. Tutanota's offer documents have not been approved by the Dutch Authority for the Financial Markets, the AFM.
ASML requests that a copy of this news release be included with all distributions of materials related to Tutanota’s mini-tender offer for ASML’s ordinary shares.
ASML historical financial information can be found on https://www.asml.com/en/investors.
| Media Relations contacts | Investor Relations contacts |
| Monique Mols +31 6 5284 4418 | Skip Miller +1 480 235 0934 |
| Sarah de Crescenzo +1 925 899 8985 | Marcel Kemp +31 40 268 6494 |
| Karen Lo +886 939788635 | Peter Cheang +886 3 659 6771 |
About ASML
ASML is a leading supplier to the semiconductor industry. The company provides chipmakers with hardware, software and services to mass produce the patterns of integrated circuits (microchips). Together with its partners, ASML drives the advancement of more affordable, more powerful, more energy-efficient microchips. ASML enables groundbreaking technology to solve some of humanity's toughest challenges, such as in healthcare, energy use and conservation, mobility and agriculture. ASML is a multinational company headquartered in Veldhoven, the Netherlands, with offices across EMEA, the US and Asia. Every day, ASML’s more than 42,400 employees (FTE) challenge the status quo and push technology to new limits. ASML is traded on Euronext Amsterdam and NASDAQ under the symbol ASML. Discover ASML – our products, technology and career opportunities – at www.asml.com.
Attachment
FAQ
What is ASML's ticker symbol and why is it mentioned in the PR?
Why does ASML recommend shareholders to reject Tutanota's offer?
What are the risks associated with Tutanota's 'mini-tender' offer?
How does Tutanota's offer compare to traditional tender offers?
What action does ASML recommend for shareholders who have already tendered their shares?
